Related Experiment Video
Updated: May 24, 2026

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
Use of mirabegron in treating overactive bladder.
Alka A Bhide1, G Alessandro Digesu, Ruwan Fernando
1Department of Urogynaecology, St. Mary's Hospital, Cambridge Wing, Praed Street, W1 1NY London, UK.
Mirabegron offers a new treatment for overactive bladder (OAB) by targeting beta-3 adrenoreceptors. Clinical studies show it effectively reduces OAB symptoms with mild side effects, presenting a promising alternative to existing therapies.
Area of Science:
- Pharmacology
- Urology
Background:
- Overactive bladder (OAB) lacks alternatives to antimuscarinics.
- Beta-3 adrenoreceptors in the bladder play a role in relaxation.
- Targeting these receptors can improve bladder capacity and compliance.
Purpose of the Study:
- To evaluate the efficacy and safety of mirabegron for OAB symptoms.
- To identify mirabegron as a potential alternative to antimuscarinic drugs.
Main Methods:
- MEDLINE literature search for mirabegron efficacy and safety.
- Searched clinical trial registries (ClinicalTrials.gov, controlled-trials.com) and FDA website.
- Included English-language articles and randomized controlled trials (RCTs) from scientific meetings.
Main Results:
- Mirabegron significantly reduced daily micturitions and incontinence episodes compared to placebo.
- Common side effects like dry mouth and GI disturbances were mild to moderate.
- A slight increase in heart rate and blood pressure was observed.
Conclusions:
- Mirabegron demonstrates efficacy in managing overactive bladder symptoms.
- It presents a promising alternative to antimuscarinic treatments.
- Further research is needed on long-term efficacy, safety, tolerability, and drug interactions (CYP2D6).
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Drugs for Treatment of Constipation-Predominant IBS
Urinary Tract Calculi III: Medical Management
